| PELBC01 | Botswana achieved the Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets: results from the Fifth Botswana HIV/AIDS Impact Survey (BAIS V), 2021 | Poster exhibition | Measuring HIV through population-based surveys (including the undiagnosed fraction) |
| PELBC02 | Identifying women at highest risk for HIV acquisition across sub-Saharan Africa: a risk assessment tool based on machine-learning methods | Poster exhibition | Epidemiology of HIV in women |
| PELBD01 | #SafeHandsSafeHearts: a randomized waitlist-controlled trial of an eHealth intervention to increase COVID-19 knowledge and protective behaviors and reduce psychological distress among LGBTQ+ people in India and Thailand | Poster exhibition | Social and behavioural aspects and approaches to COVID-19 |
| PELBD02 | Implementation of the first PrEP counseling and adherence protocol in a country with high need for and low access to biomedical HIV prevention | Poster exhibition | Gay men other men who have sex with men |
| PELBE01 | Pre-exposure prophylaxis for people who inject drugs: opportunities to expand the program in Ukraine | Poster exhibition | Implementation science of scaling up prevention (including PrEP) |
| PELBE02 | Community led monitoring in PEPFAR Vietnam - innovation and lessons learned | Poster exhibition | Effective approaches to linking population and programme data to inform HIV programming |
| PELBF01 | HIV criminalization laws, public health trust, and uptake of COVID-19 vaccine among people living with HIV in the United States | Poster exhibition | Laws and policies on HIV transmission, exposure, and non-disclosure |
| PELBF02 | Follow the science - addressing resistance to comprehensive sexuality education: lessons from five African countries | Poster exhibition | Laws, policies and practices impacting access to HIV testing, prevention, treatment, care and support |
| PEMOA26 | Developing a novel HIV cure strategy: retargeting potent cytotoxic T cells to kill HIV-infected cells | Poster exhibition | Immunotherapy (including broadly neutralizing antibodies) |
| PEMOA27 | Clinical and immunometabolic patterns determining efficacy of DC-treatment reinvigorating HIV-1-specific CD8+ T cells in PLWH | Poster exhibition | Immunotherapy (including broadly neutralizing antibodies) |